UiPath Inc. (NYSE:PATH – Get Free Report) has been assigned a consensus rating of “Hold” from the nineteen brokerages that are presently covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, sixteen have given a hold rating and two have issued a buy rating on the company. The average 12 month price target among brokerages that have covered the stock in the last year is $17.50.
A number of research firms have recently commented on PATH. BMO Capital Markets increased their price target on shares of UiPath from $15.00 to $16.00 and gave the company a “market perform” rating in a report on Friday, December 6th. DA Davidson increased their target price on UiPath from $13.00 to $15.00 and gave the company a “neutral” rating in a research note on Friday, September 6th. Needham & Company LLC restated a “hold” rating on shares of UiPath in a research note on Friday, December 6th. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $16.00 price objective on shares of UiPath in a research report on Friday, December 6th. Finally, Wells Fargo & Company reduced their price objective on UiPath from $15.00 to $13.00 and set an “equal weight” rating for the company in a report on Wednesday, October 23rd.
Check Out Our Latest Report on UiPath
Institutional Trading of UiPath
UiPath Price Performance
Shares of UiPath stock opened at $14.01 on Friday. The firm has a market cap of $7.70 billion, a price-to-earnings ratio of -87.56 and a beta of 0.94. UiPath has a 1 year low of $10.37 and a 1 year high of $27.87. The company has a 50-day moving average of $13.32 and a 200 day moving average of $12.62.
UiPath Company Profile
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
Further Reading
- Five stocks we like better than UiPath
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- What is the Dow Jones Industrial Average (DJIA)?
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Which Wall Street Analysts are the Most Accurate?
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.